Why is CELC Skyrocketing in Premarket Trading Today?

Celcuity's stock surged over 112% in premarket trading following positive Phase 3 trial results for its breast cancer treatment, marking a potential breakthrough in targeted cancer therapy. source: https://tokenist.com/why-is-celc-skyrocketing-in-premarket-trading-today/?utm_source=rss&utm_medium=rss&utm_campaign=why-is-celc-skyrocketing-in-premarket-trading-today